Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Prentki Ronald J
Relationship:   President & CEO, Direc...
City:   Greenwich
State:   CT
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   74,117    

Indirect Shares

  6,860      
Direct Value   $249,963    

Indirect Value

  $19,002      
Total Shares   80,977      
Total Value   $268,965      


Progenics Pharmaceuticals Inc
 $137,670 Heron Therapeutics Inc
 $112,293 Progenics Pharmaceuticals Inc
 $137,670 Heron Therapeutics Inc
 $112,293
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Progenics Pharmaceuticals Inc PGNX President, Director 2005-02-07 33,578 2003-07-01 0    Premium*  
            Heron Therapeutics Inc HRTX President & CEO, Direc... 2009-07-08 40,539 2009-07-08 6,860    Premium*  
* Premium Members only  

Records found :    51         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
PGNX Progenics Pharmaceuticals... President   •       •      –    2003-07-01 4 A $11.92 $30,289 D/D 2,541 13,690 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2003-10-01 4 A $11.94 $30,829 D/D 2,582 16,272 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-01-05 4 A $11.41 $2,510 D/D 220 16,492 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-01 4 A $11.51 $1,634 D/D 142 16,634 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-19 4 OE $9.25 $27,750 D/D 3,000 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-19 4 AS $19.80 $59,450 D/D (3,000) 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-20 4 AS $19.90 $59,900 D/D (3,000) 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-20 4 OE $9.25 $27,750 D/D 3,000 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-21 4 OE $9.25 $46,250 D/D 5,000 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-21 4 AS $19.50 $98,275 D/D (5,000) 16,634 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-22 4 OE $9.25 $69,375 D/D 7,500 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-22 4 AS $19.80 $149,140 D/D (7,500) 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-23 4 AS $19.93 $69,825 D/D (3,500) 16,634 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-23 4 OE $9.25 $32,375 D/D 3,500 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-26 4 OE $9.25 $27,750 D/D 3,000 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-26 4 AS $19.80 $59,650 D/D (3,000) 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-27 4 OE $9.25 $46,250 D/D 5,000 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-04-27 4 AS $19.90 $99,920 D/D (5,000) 16,634 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-05-03 4 AS $19.25 $57,830 D/D (3,000) 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-05-03 4 OE $9.25 $27,750 D/D 3,000 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-05-04 4 OE $9.25 $46,250 D/D 5,000 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-05-04 4 AS $19.40 $97,460 D/D (5,000) 16,634 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-05-05 4 OE $9.25 $37,000 D/D 4,000 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-05-05 4 AS $19.40 $78,100 D/D (4,000) 0 -
PGNX Progenics Pharmaceuticals... President   •       •      –    2004-05-06 4 AS $19.40 $58,725 D/D (3,000) 16,634 -

  51  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed